(Q34742733)

4 August 2017

title

Diffusion-weighted MRI and its role in prostate cancer (English)

1 reference

4 August 2017

1 reference

Tsutomu Tamada

1

1 reference

4 August 2017

Teruki Sone

2

1 reference

4 August 2017

Yoshimasa Jo

3

1 reference

4 August 2017

Akira Yamamoto

4

1 reference

4 August 2017

Katsuyoshi Ito

5

1 reference

4 August 2017

publication date

27 May 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

27

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

25-38

1 reference

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

4 August 2017

cites work

1 reference

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries

21 January 2018

1 reference

Contemporary trends in low risk prostate cancer: risk assessment and treatment

21 January 2018

1 reference

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

21 January 2018

1 reference

Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer

21 January 2018

1 reference

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

Diffusion weighted imaging in prostate cancer

21 January 2018

1 reference

Diffusion-weighted MR imaging of the brain

21 January 2018

1 reference

Diffusion-weighted MRI in the body: applications and challenges in oncology

21 January 2018

1 reference

Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging

21 January 2018

1 reference

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

21 January 2018

1 reference

Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging

21 January 2018

1 reference

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

21 January 2018

1 reference

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

21 January 2018

1 reference

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging

21 January 2018

1 reference

Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images

21 January 2018

1 reference

Use of MR exponential diffusion-weighted images to eradicate T2 "shine-through" effect

21 January 2018

1 reference

Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer

21 January 2018

1 reference

Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer

21 January 2018

1 reference

Advancements in MR imaging of the prostate: from diagnosis to interventions

21 January 2018

1 reference

21 January 2018

1 reference

Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.

21 January 2018

1 reference

Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

21 January 2018

1 reference

Genitourinary applications of diffusion-weighted MR imaging in the pelvis

21 January 2018

1 reference

Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues

21 January 2018

1 reference

Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.

21 January 2018

1 reference

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings

21 January 2018

1 reference

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

21 January 2018

1 reference

Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.

21 January 2018

1 reference

Diffusion tensor imaging of the normal prostate at 3 Tesla.

21 January 2018

1 reference

Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.

21 January 2018

1 reference

High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.

21 January 2018

1 reference

Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).

21 January 2018

1 reference

Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer

21 January 2018

1 reference

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness

21 January 2018

1 reference

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

21 January 2018

1 reference

Multidisciplinary functional MR imaging for prostate cancer

21 January 2018

1 reference

Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective

21 January 2018

1 reference

Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.

21 January 2018

1 reference

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

21 January 2018

1 reference

Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging

21 January 2018

1 reference

Functional MR imaging of prostate cancer

21 January 2018

1 reference

Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer

21 January 2018

1 reference

The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.

21 January 2018

1 reference

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

21 January 2018

1 reference

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

21 January 2018

1 reference

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study

21 January 2018

1 reference

Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.

21 January 2018

1 reference

The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

Diffusion-weighted imaging of the liver: technical challenges and prospects for the future

21 January 2018

1 reference

Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.

21 January 2018

1 reference

MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores

21 January 2018

1 reference

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values.

21 January 2018

1 reference

Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.

21 January 2018

1 reference

Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.

21 January 2018

1 reference

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience

21 January 2018

1 reference

Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results

21 January 2018

1 reference

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.

21 January 2018

1 reference

Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.

21 January 2018

1 reference

MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

21 January 2018

1 reference

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study

21 January 2018

1 reference

Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning

21 January 2018

1 reference

Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer

21 January 2018

1 reference

Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy

21 January 2018

1 reference

Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations

21 January 2018

1 reference

Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.

21 January 2018

1 reference

Biexponential apparent diffusion coefficients in prostate cancer.

21 January 2018

1 reference

Diffusion-weighted MRI: a new functional clinical technique for tumour imaging

21 January 2018

1 reference

Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate

21 January 2018

1 reference

Prostate cancer vs. post-biopsy hemorrhage: Diagnosis with T2- and diffusion-weighted imaging

21 January 2018

1 reference

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/NBM.2956

1 reference

4 August 2017

1 reference